Back
Arcellx Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
20
ACLX
Arcellx
Last Price:
51.83
Seasonality Move:
34.3%
Buy
53
SRPT
Sarepta Therapeutics
Last Price:
128.73
Seasonality Move:
13.16%
Sell
20
Arcellx (ACLX)
is a Sell
Is Arcellx a Buy, Sell or Hold?
- The current Arcellx [ACLX] share price is $51.92. The Score for ACLX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ACLX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
53
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $128.77. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACLX Stock Price Chart
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $128.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
ACLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.81 | Sell |
| Relative Strength Index (14 RSI): | 31.99 | Sell |
| Chaikin Money Flow: | 54393 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.59 - 66.49) | Sell |
| Bollinger Bands (100): | (53.7 - 67.1) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 61.94 | Buy |
| Chaikin Money Flow: | 75361 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.46 - 128.88) | Buy |
| Bollinger Bands (100): | (102.26 - 131.28) | Buy |
ACLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.78 | Sell |
| 20-day SMA: | 57.59 | Sell |
| 50-day SMA: | 63.79 | Sell |
| 200-day SMA: | 49.03 | Buy |
| 8-day EMA: | 53.34 | Sell |
| 20-day EMA: | 57.15 | Sell |
| 50-day EMA: | 60.51 | Sell |
| 200-day EMA: | 51.86 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 120.54 | Buy |
| 20-day SMA: | 123.05 | Buy |
| 50-day SMA: | 126 | Buy |
| 200-day SMA: | 111.6 | Buy |
| 8-day EMA: | 123.02 | Buy |
| 20-day EMA: | 122.89 | Buy |
| 50-day EMA: | 122.67 | Buy |
| 200-day EMA: | 116.01 | Buy |
Arcellx Earnings Growth & ACLX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.22 per share, an increase this year of $0.68 per share, and a decrease next year of $0.14 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.72 per share, an increase next quarter of $3.22 per share, an increase this year of $5.19 per share, and an increase next year of $7.23 per share.
Arcellx Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||